Leonard William D'Avolio, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| User-Computer Interface | 4 | 2011 | 1400 | 0.840 |
Why?
|
| Natural Language Processing | 9 | 2016 | 1162 | 0.740 |
Why?
|
| Data Mining | 4 | 2013 | 551 | 0.660 |
Why?
|
| Nursing Process | 1 | 2016 | 17 | 0.560 |
Why?
|
| Electronic Health Records | 10 | 2016 | 4811 | 0.500 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2012 | 1192 | 0.470 |
Why?
|
| Medical Informatics | 2 | 2010 | 733 | 0.420 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 162 | 0.380 |
Why?
|
| Workload | 1 | 2016 | 844 | 0.360 |
Why?
|
| Medical Order Entry Systems | 2 | 2012 | 521 | 0.340 |
Why?
|
| Comparative Effectiveness Research | 3 | 2012 | 709 | 0.330 |
Why?
|
| Community-Acquired Infections | 1 | 2013 | 469 | 0.330 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2012 | 928 | 0.320 |
Why?
|
| Algorithms | 9 | 2016 | 14031 | 0.270 |
Why?
|
| Software | 3 | 2013 | 4434 | 0.260 |
Why?
|
| Point-of-Care Systems | 2 | 2012 | 1213 | 0.260 |
Why?
|
| Financing, Government | 1 | 2009 | 472 | 0.260 |
Why?
|
| Genetic Markers | 1 | 2011 | 2601 | 0.250 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2011 | 1175 | 0.240 |
Why?
|
| Prostatectomy | 3 | 2008 | 1824 | 0.220 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 710 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2016 | 2578 | 0.200 |
Why?
|
| Insulin | 3 | 2023 | 6596 | 0.190 |
Why?
|
| Pneumonia | 1 | 2013 | 2143 | 0.190 |
Why?
|
| Health Services Research | 1 | 2008 | 1812 | 0.180 |
Why?
|
| Prostatic Neoplasms | 5 | 2011 | 11118 | 0.170 |
Why?
|
| Quality of Health Care | 3 | 2011 | 4330 | 0.170 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 1007 | 0.170 |
Why?
|
| Computer Graphics | 2 | 2008 | 340 | 0.130 |
Why?
|
| Databases as Topic | 2 | 2008 | 473 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2016 | 8631 | 0.120 |
Why?
|
| Manipulation, Spinal | 1 | 2014 | 21 | 0.120 |
Why?
|
| Hospitals, Community | 1 | 2016 | 365 | 0.120 |
Why?
|
| Vertebral Artery Dissection | 1 | 2014 | 51 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5840 | 0.110 |
Why?
|
| Psychotherapy | 2 | 2013 | 1647 | 0.110 |
Why?
|
| Urinary Catheterization | 1 | 2012 | 193 | 0.100 |
Why?
|
| Software Validation | 1 | 2010 | 59 | 0.090 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 273 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 250 | 0.080 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2009 | 88 | 0.080 |
Why?
|
| International Classification of Diseases | 2 | 2014 | 909 | 0.080 |
Why?
|
| Veterans | 2 | 2013 | 2647 | 0.080 |
Why?
|
| Mastectomy | 1 | 2016 | 1822 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3415 | 0.080 |
Why?
|
| Research Design | 3 | 2012 | 6180 | 0.070 |
Why?
|
| Workflow | 1 | 2012 | 851 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 20098 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2016 | 1239 | 0.070 |
Why?
|
| Commerce | 1 | 2011 | 606 | 0.070 |
Why?
|
| Reimbursement Mechanisms | 1 | 2011 | 667 | 0.060 |
Why?
|
| Medical Records | 1 | 2011 | 1408 | 0.060 |
Why?
|
| Outpatients | 1 | 2013 | 1597 | 0.060 |
Why?
|
| Body Height | 1 | 2011 | 1570 | 0.060 |
Why?
|
| Unified Medical Language System | 1 | 2005 | 89 | 0.060 |
Why?
|
| Colonoscopy | 1 | 2012 | 1394 | 0.060 |
Why?
|
| Humans | 23 | 2023 | 761504 | 0.060 |
Why?
|
| United States | 7 | 2023 | 72334 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2013 | 4575 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2012 | 2330 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 15266 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2011 | 1376 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2012 | 2598 | 0.050 |
Why?
|
| Cholesterol | 1 | 2011 | 2904 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3688 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3358 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2005 | 763 | 0.050 |
Why?
|
| Hospitals, Veterans | 2 | 2013 | 395 | 0.040 |
Why?
|
| Patient Selection | 1 | 2012 | 4244 | 0.040 |
Why?
|
| Prostate | 1 | 2007 | 1770 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3639 | 0.040 |
Why?
|
| New England | 2 | 2013 | 1054 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 5440 | 0.040 |
Why?
|
| Documentation | 1 | 2005 | 897 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2011 | 3242 | 0.040 |
Why?
|
| Length of Stay | 1 | 2011 | 6425 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 11121 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3245 | 0.030 |
Why?
|
| Male | 9 | 2014 | 360804 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8708 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 58976 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 10209 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 1922 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2005 | 3575 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2023 | 1421 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14666 | 0.030 |
Why?
|
| Aged | 6 | 2016 | 169289 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12690 | 0.020 |
Why?
|
| Veterans Health | 1 | 2013 | 215 | 0.020 |
Why?
|
| Hospitals, Public | 1 | 2012 | 202 | 0.020 |
Why?
|
| Poverty | 1 | 2023 | 2698 | 0.020 |
Why?
|
| Lovastatin | 1 | 2011 | 115 | 0.020 |
Why?
|
| Middle Aged | 6 | 2016 | 220895 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2014 | 9646 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 190 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13255 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 21012 | 0.020 |
Why?
|
| Adult | 4 | 2023 | 221177 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2011 | 344 | 0.020 |
Why?
|
| Pravastatin | 1 | 2011 | 392 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2011 | 395 | 0.020 |
Why?
|
| Simvastatin | 1 | 2011 | 346 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2023 | 6391 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 12059 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 29625 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 59243 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 802 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 2358 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2927 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 88319 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5336 | 0.010 |
Why?
|
| Pyrroles | 1 | 2011 | 1125 | 0.010 |
Why?
|
| Colon | 1 | 2012 | 1792 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2011 | 966 | 0.010 |
Why?
|
| Cross Infection | 1 | 2012 | 1422 | 0.010 |
Why?
|
| Female | 4 | 2016 | 392644 | 0.010 |
Why?
|
| Indoles | 1 | 2011 | 1833 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2024 | 0.010 |
Why?
|
| Neoplasms | 1 | 2010 | 22170 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2005 | 683 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 2169 | 0.010 |
Why?
|
| Body Weight | 1 | 2011 | 4618 | 0.010 |
Why?
|
| Lipids | 1 | 2011 | 3341 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18395 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2422 | 0.010 |
Why?
|
| Mass Screening | 1 | 2012 | 5428 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12463 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15842 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21353 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 23995 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 41487 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80636 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74206 | 0.000 |
Why?
|